MOLETI, MARIA LUISA
 Distribuzione geografica
Continente #
NA - Nord America 1.332
EU - Europa 988
AS - Asia 361
AF - Africa 16
SA - Sud America 14
OC - Oceania 1
Totale 2.712
Nazione #
US - Stati Uniti d'America 1.306
IT - Italia 670
SG - Singapore 190
SE - Svezia 146
IN - India 85
CN - Cina 69
GB - Regno Unito 37
DE - Germania 30
CA - Canada 26
RO - Romania 17
TG - Togo 15
UA - Ucraina 15
BG - Bulgaria 14
FI - Finlandia 14
IE - Irlanda 12
CH - Svizzera 8
ES - Italia 8
AR - Argentina 7
BR - Brasile 6
ID - Indonesia 5
BE - Belgio 4
TR - Turchia 4
AL - Albania 2
FR - Francia 2
NL - Olanda 2
PH - Filippine 2
RU - Federazione Russa 2
SA - Arabia Saudita 2
SI - Slovenia 2
BA - Bosnia-Erzegovina 1
CL - Cile 1
IL - Israele 1
IR - Iran 1
JP - Giappone 1
LT - Lituania 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
ZA - Sudafrica 1
Totale 2.712
Città #
Fairfield 186
Chandler 165
Singapore 147
Rome 123
Seattle 84
Ashburn 75
Woodbridge 70
Houston 66
Wilmington 64
Santa Clara 54
Cambridge 46
Princeton 43
Beijing 42
San Paolo di Civitate 32
Milan 31
Millbury 30
Plano 28
Lawrence 24
Florence 20
Ann Arbor 19
Naples 19
Turin 17
Bremen 16
San Diego 16
Lomé 15
Toronto 15
Sofia 14
Bari 12
Boston 12
Dublin 12
Ottawa 11
Palermo 11
Andover 10
New York 10
Venice 10
Bologna 9
Norwalk 9
Atella 8
Carmarthen 8
Catania 8
Des Moines 8
Birkenhead 7
Federal 7
Helsinki 7
Genoa 6
Arluno 5
Columbus 5
Jakarta 5
Madrid 5
Montopoli in Val d'Arno 5
Southend 5
Buffalo 4
Bühl 4
Jacksonville 4
London 4
Timisoara 4
Voghera 4
Belo Horizonte 3
Bern 3
Brookline 3
Brussels 3
Cattolica 3
Conegliano 3
Dearborn 3
Fonte Nuova 3
Frankfurt am Main 3
Hefei 3
Mondovì 3
Monte Porzio 3
Montesilvano Marina 3
Pavia 3
Perugia 3
Pisa 3
Pune 3
Redmond 3
San Giuseppe Vesuviano 3
Tortoreto 3
Afragola 2
Amelia 2
Angeles City 2
Ankara 2
Arezzo 2
Barcelona 2
Bevagna 2
Bonate Sopra 2
Brugherio 2
Cagliari 2
Cascina 2
Castel Ritaldi 2
Caulonia 2
Cesenatico 2
Città Sant'Angelo 2
Cwmbran 2
Grassobbio 2
Gravina in Puglia 2
Gualtieri 2
Istanbul 2
Kunming 2
Ljubljana 2
Los Angeles 2
Totale 1.786
Nome #
Esperienza con l'imatinib ad intermittenza nei bambini e adolescenti con leucemia mieloide cronica (LMC): risultati e prospettive 213
Terapia con Idrossiurea in bambini e adolescenti affetti da anemia falciforme nel “real life setting 141
LOCALIZZAZIONE EXTRAMIDOLLARE DI LAM IN ETÀ PEDIATRICA: IL RUOLO DI UNA CORRETTA E TEMPESTIVA DIAGNOSI 130
Treatment-free remission after imatinib discontinuation is possible in paediatric patients with chronic myeloid leukaemia. 107
Epstein-Barr virus–positive diffuse large B-cell lymphoma in children: a disease reminiscent of Epstein-Barr virus–positive diffuse large B-cell lymphoma of the elderly 93
Atypical chronic myeloid leukemia in a patient with aplastic anemia 91
Early response does not predict outcome in children and adolescents with chronic myeloid leukaemia treated with high-dose imatinib 87
EFFICACIA DEL PEG-IFNΑ-2A IN UN CASO DI POLICITEMIA VERA PEDIATRICA 85
Real-Life Management of Children and Adolescents with Chronic Myeloid Leukemia: The Italian Experience 83
INDOMETHACIN AS FIRST LINE TREATMENT OF LANGERHANS CELL HISTIOCYTOSIS (LCH). A 20-YEAR EXPERIENCE OF A SINGLE CENTRE. 76
Can chronic myeloid leukaemia in children and adolescents be successfully treated without haematopoietic stem cell transplant? A single centre experience 76
Gamma-delta hepatosplenic T-cell lymphoma. Description of a case with immunophenotypic and molecular follow-up succesfully treated with chemotherapy alone 71
EFFICACIA E SICUREZZA DELL’IMPIEGO DEI PICC IN PAZIENTI PEDIATRICI AFFETTI DA LEUCEMIA ACUTA: ESPERIENZA MONOCENTRICA 66
null 64
Intermittent Imatinib mesylate in children with chronic myeloid leukemia: results and outcome 64
Specific guidelines including multidisciplinary approach is critical of management of Langerhans Cell Histiocytosis in adults 63
Management of Chronic Myeloid Leukemia in children and adolescents according to local guidelines the Italian experience 60
Early Response Does Not Impact on the Long-Term Outcome of Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience. 58
Proven Epstein-Barr encephalitis with negative EBV-DNA load in cerebrospinal fluid after allogeneic hematopoietic stem cell transplantation in a child with acute lymphoblastic leukemia 57
Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors 57
Polyostotic Fibrous Dysplasia Mimicking Bone Involvement in Hodgkin Lymphoma: A Pediatric Case and Literature Review 55
Response to High Dose Imatinib and Long-Term Outcome in Children and Adolescents with Previously Untreated Chronic Myeloid Leukemia in Chronic Phase. the Italian Experience. 53
Applicazione della classificazione WHO 2016 IN 80 bambini e adolescenti con neoplasie mieloproliferative croniche 51
Next-Generation Sequencing (NGS) in childhood Myeloproliferative Diseases (MPD) 51
Chronic Thrombocytopenia in Children: What Could It Hide? 51
Trombocitopenia Idiopatica (ITP) cronica. cosa puo’ nascondere? 50
Severe rituximab-induced pneumonitis in an immunocompromised child with acquired thrombotic thrombocytopenic purpura 49
UTILITA’ DELLA TECNICA NEXT GENERATION SEQUENCING (NGS) NELL’IDENTIFICAZIONE DI GENI NON-DRIVER IN PAZIENTI CON MALATTIE MIELOPROLIFERATIVE CRONICHE (MMC) PEDIATRICHE WILD TYPE: ESPERIENZA DI UN SINGOLO CENTRO 47
Results and outcome of intermittent imatinib (ON/OFF schedule) in children and adolescents with chronic myeloid leukaemia 47
Autoimmune Hemolitic Anemia in a Boy With Inactive Ulcerative Colitis 46
Iron deficiency in children and adolescents: an alarm bell for gastrointestinal diseases. 43
EFFICACY OF INDOMETHACIN AS SALVAGE THERAPY IN CHILDREN AND ADULTS WITH LANGERHANS CELL HISTIOCYTOSIS WITH BONE INVOLVEMENT 43
null 43
Managing Children and Adolescents with Chronic Myeloid Leukemia Treated with High-Dose Imatinib. The Italian Experience. 41
Primary Trombocythemia in Children and Adolescents Includes Different Subtypes Compared to Adult Essential Thrombocythemia 39
Long-term Outcome in Children and Adolescents with Chronic Myeloid Leukemia in Chronic Phase Treated with High-Dose Imatinib. The Italian Experience. 38
Discontinuation of Imatinib (IM) in pediatrica chronic myeloid leukemia (CML) patients with sustained complete molecular remission (CMR). 35
Reduced mortality from KPC-K.pneumoniae bloodstream infection in high-risk patients with hematological malignancies colonized by KPC-K.pneumoniae 35
Incidence and outcome of infections after unrelated cord blood transplantation in patients with hematological malignancies: a long-term single center experience 33
Efficacy of ibrutinib as salvage treatment in a secondary central nervous system lymphoma (SCNSL) progressed after chemorefractory Primary Mediastinal B Cell Lymphoma (PMBCL) 33
P1580: MANAGEMENT OF PATIENTS WITH MASTOCYTOSIS DURING THE COVID-19 PANDEMIC: A SINGLE CENTER EXPERIENCE 30
A long-term outcome for patients with high-risk leukemia undergoing an unrelated cord blood transplant (CBT) 29
P1006: NEXT GENERATION SEQUENCING (NGS) IN PEDIATRIC MASTOCYTOSIS 29
P981: NEXT GENERATION SEQUENCING (NGS): AN IMPORTANT TOOL TO CHARACTERIZE MYELOPROLIFERATIVE DISEASES IN CHILDREN 28
null 27
WHO 2016 classification in 80 children and adolescents with chronic myeloproliferative neoplasms 27
Acquired thrombotic thrombocytopenic purpura in a child: Rituximab to prevent relapse. A pediatric report and literature review 24
Fifteen years of iodine prophylaxis in Italy. Results of a nationwide surveillance (Period 2015-2019) 18
null 18
Challenging Management of Severe Differentiation Syndrome in Pediatric Acute Promyelocytic Leukemia Treated with ATRA/ATO 17
Long-term results with the adapted LMB 96 protocol in children with B-cell non Hodgkin lymphoma treated in Iraq: comparison in two subsequent cohorts of patients 15
LAL PH+ IN ETÀ PEDIATRICA: VALUTAZIONE DELLA MALATTIA MINIMA RESIDUA E RUOLO DELLA TERAPIA CON INIBITORI DELLA TIROSINCHINASI (TKI) 15
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-K. pneumoniae in Febrile Neutropenic Patients with Acute Leukemia Who are Colonized with KPC-K. pneumoniae. A 7-Years Retrospective Observational Cohort Study 13
HODGKIN LYMPHOMA IN CHILDREN: A 16-YEAR EXPERIENCE AT THE CHILDREN’S WELFARE TEACHING HOSPITAL OF BAGHDAD, IRAQ 3
null 3
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study 2
Totale 2.923
Categoria #
all - tutte 7.931
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 7.931


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020287 0 0 0 0 0 61 45 47 43 40 27 24
2020/2021193 15 15 4 17 21 3 10 22 38 14 21 13
2021/2022419 20 18 21 26 66 27 6 35 32 23 71 74
2022/2023596 85 93 36 73 65 71 7 36 82 9 18 21
2023/2024557 34 44 40 39 50 28 34 33 19 99 54 83
2024/2025479 86 140 60 76 115 2 0 0 0 0 0 0
Totale 2.923